You are here
20 20 Genesystems Inc
UEI: N/A
# of Employees: 20
HUBZone Owned: No
Socially and Economically Disadvantaged: Yes
Woman Owned: Yes
Award Charts
Award Listing
-
IGF::OT::IGF RandD- MEDICAL: BIOMEDICAL (BASIC RESEARCH)
Amount: $749,959.00Not Available
SBIRPhase II2014Department of Health and Human Services National Institutes of Health -
A COMPANION DIAGNOSTIC FOR PROGNOSIS OF KIDNEY CANCER
Amount: $199,597.00This contract was awarded by the National Cancer Institute's Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) Program under the funding opportunity "Contract Top ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health -
PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm
Amount: $2,750,000.00DESCRIPTION (provided by applicant): The promise of personalized medicine relies on the development of diagnostic tests to categorize patients within small cohorts who will benefit from specific treat ...
SBIRPhase II2010Department of Health and Human Services National Institutes of Health -
Autoantibody Profiling for Serological Detection of Head and Neck Cancer
Amount: $217,801.00DESCRIPTION (provided by applicant): SBIR grant support is being sought by 20/20 GeneSystems, Inc. (20/20), a small biotech company, to help us advance what we believe will become the first blood test ...
SBIRPhase I2009Department of Health and Human Services National Institutes of Health -
Profiling Autoantibodies in Non-small Cell Lung Cancer with Fusion Protein-Peptid
Amount: $183,927.00DESCRIPTION (provided by applicant): Approximately 135,000 new cases of non-small cell lung cancer (NSCLC) are diagnosed each year in the USA, yet only 20%-25% of those patients will be diagnosed at a ...
SBIRPhase I2009Department of Health and Human Services National Institutes of Health -
Profiling ER, PR, EGFR and HER2 in Breast Cancer Using Multiplex Tissue Immusta
Amount: $649,622.00DESCRIPTION (provided by applicant): We propose to develop a novel method and kit for profiling the expression and activation of signal transduction proteins in breast tumors. The goal is to create ne ...
SBIRPhase II2008Department of Health and Human Services National Institutes of Health -
Profiling EGFR and Her2 in Breast Cancer using Multiplex Tissue Immunostaining
Amount: $117,930.00DESCRIPTION (provided by applicant): We propose to develop a novel method and kit for profiling the expression and activation of signal transduction proteins in breast tumors. The goal is to create ne ...
SBIRPhase I2007Department of Health and Human Services National Institutes of Health -
Peptide Array for Profiling of Autoantibodies in Non-small Cell Lung Cancer
Amount: $165,288.00DESCRIPTION (provided by applicant): Approximately 135,000 new cases of non-small cell lung cancer (NSCLC) are diagnosed each year in the USA, yet only 20%-25% of those patients will be diagnosed at a ...
SBIRPhase I2007Department of Health and Human Services National Institutes of Health -
Auto-antibody profiling of non-small cell lung cancer
Amount: $177,279.00DESCRIPTION (provided by applicant): Tumor markers, measured in peripheral blood, could assist in diagnosis and management of non-small cell lung cancer (NSCLC) and potentially improve historically di ...
STTRPhase I2006Department of Health and Human Services National Institutes of Health -
Auto-antibody profiling of non-small cell lung cancer
Amount: $177,279.00DESCRIPTION (provided by applicant): Tumor markers, measured in peripheral blood, could assist in diagnosis and management of non-small cell lung cancer (NSCLC) and potentially improve historically di ...
SBIRPhase I2006Department of Health and Human Services National Institutes of Health
